FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-03Mar 07, 2023
Drug Development
Novartis Licenses First-in-Class Heart Disease Drug
Emilie Branch
Pharma's Almanac
PAO-M03-19-NI-008Mar 05, 2019
FDA Analysis
FDA Analysis Shows Reduced Competition for First-in-Class Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-18-NI-002Jul 31, 2018